Protalix BioTherapeutics, Inc.
PLX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001006281
No open-market purchases or sales by Protalix BioTherapeutics, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $33.7M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Protalix BioTherapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +2 vs. Q2 2021
- Shares held
- 4.42M
- +98.5K (+2.3%) vs. Q2 2021
- Total value
- $5.91M
- −$2.33M (−28.3%) vs. Q2 2021
- New holders
- 7
- 10 more added
- Sold out
- 5
- 10 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $33.7M |
| Q1 2026 | 100 | $36.6M |
| Q4 2025 | 83 | $26.8M |
| Q3 2025 | 77 | $30.9M |
| Q2 2025 | 63 | $17.6M |
| Q1 2025 | 63 | $21.0M |
| Q4 2024 | 46 | $8.40M |
| Q3 2024 | 45 | $3.53M |
| Q2 2024 | 66 | $6.60M |
| Q1 2024 | 64 | $11.9M |
| Q4 2023 | 66 | $17.6M |
| Q3 2023 | 61 | $15.2M |
| Q2 2023 | 66 | $17.9M |
| Q1 2023 | 34 | $6.15M |
| Q4 2022 | 26 | $4.87M |
| Q3 2022 | 27 | $3.70M |
| Q2 2022 | 30 | $1.30M |
| Q1 2022 | 32 | $1.29M |
| Q4 2021 | 31 | $2.45M |
| Q3 2021 | 35 | $5.91M |
| Q2 2021 | 33 | $8.24M |
| Q1 2021 | 38 | $39.4M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Protalix BioTherapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 500 | $1.00K | 0.00% | −620−55.4% | Reduced |
| Captrust Financial Advisors | 800 | $1.00K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Ten Capital Wealth Advisors, LLC | 552 | $1.00K | 0.00% | +227+69.8% | Added |
| Federation des caisses Desjardins du Quebec | 1,100 | $1.46K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,314 | $3.00K | 0.00% | +389+20.2% | Added |
| Harbour Investments, Inc. | 3,000 | $4.00K | 0.00% | +3,000 | New |
| Migdal Insurance & Financial Holdings Ltd. | 4,000 | $5.00K | 0.00% | +4,000 | New |
| Federated Hermes, Inc. | 5,761 | $8.00K | 0.00% | 00.0% | Unchanged |
| Psagot Investment House Ltd. | 6,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 5,847 | $8.00K | 0.00% | +5,847 | New |
| Psagot Value Holdings Ltd. / (Israel) | 6,000 | $8.00K | 0.00% | +6,000 | New |
| Bank of America Corp | 8,890 | $12.0K | 0.00% | +3,017+51.4% | Added |
| Cutler Group LP | 11,267 | $14.0K | 0.00% | +4,367+63.3% | Added |
| Two Sigma Advisers, LP | 14,200 | $19.0K | 0.00% | +14,200 | New |
| Spire Wealth Management | 18,000 | $24.0K | 0.00% | +4,000+28.6% | Added |
| XTX Topco Ltd | 20,514 | $27.0K | 0.01% | +3,366+19.6% | Added |
| Citadel Advisors LLC | 24,945 | $34.0K | 0.00% | −90,941−78.5% | Reduced |
| Wolverine Trading, LLC | 28,168 | $39.0K | 0.00% | −17,138−37.8% | Reduced |
| Credit Suisse AG | 31,974 | $43.0K | 0.00% | −33,951−51.5% | Reduced |
| IHT Wealth Management, LLC | 33,200 | $44.0K | 0.00% | +33,200 | New |
| Davenport & Co LLC | 36,000 | $48.0K | 0.00% | +24,000+200.0% | Added |
| Jane Street Group, LLC | 40,949 | $54.0K | 0.00% | +9,284+29.3% | Added |
| Bridgeway Capital Management, LLC | 58,890 | $78.0K | 0.00% | −335,000−85.0% | Reduced |
| Susquehanna Fundamental Investments, LLC | 59,500 | $79.0K | 0.00% | −6,600−10.0% | Reduced |
| Walleye Trading LLC | 81,000 | $108.0K | 0.00% | −54,000−40.0% | Reduced |
| Simplex Trading, LLC | 69,049 | $129.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 119,555 | $159.0K | 0.00% | −2,944−2.4% | Reduced |
| Walleye Capital LLC | 220,089 | $293.0K | 0.01% | −126,450−36.5% | Reduced |
| Group One Trading, L.P. | 222,553 | $296.0K | 0.01% | +43,465+24.3% | Added |
| Meitav Dash Investments Ltd | 244,332 | $325.0K | 0.01% | 00.0% | Unchanged |
| Phoenix Holdings Ltd. | 244,113 | $325.0K | 0.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 251,171 | $334.0K | 0.00% | −31,974−11.3% | Reduced |
| Gsa Capital Partners LLP | 254,871 | $339.0K | 0.03% | +254,871 | New |
| Morgan Stanley | 2,285,075 | $3.04M | 0.00% | +423,256+22.7% | Added |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −30,075−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,658−100.0% | Sold out |
| Red Door Wealth Management, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −873−100.0% | Sold out |
| Gemmer Asset Management LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |